Tyra Biosciences
TYRA
TYRA
77 hedge funds and large institutions have $768M invested in Tyra Biosciences in 2024 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
24% more funds holding
Funds holding: 62 → 77 (+15)
6.09% more ownership
Funds ownership: 83.12% → 89.21% (+6.1%)
85% less call options, than puts
Call options by funds: $10K | Put options by funds: $67K
Holders
77
Holding in Top 10
5
Calls
$10K
Puts
$67K
Top Buyers
| 1 | +$52.2M | |
| 2 | +$31.5M | |
| 3 | +$25.2M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$19.8M |
| 5 |
O
OrbiMed
New York
|
+$12.6M |
Top Sellers
| 1 | -$3.18M | |
| 2 | -$1.9M | |
| 3 | -$782K | |
| 4 |
Morgan Stanley
New York
|
-$592K |
| 5 |
JPMorgan Chase & Co
New York
|
-$346K |